Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 4
2005 1
2006 2
2007 4
2008 4
2009 4
2010 6
2011 4
2012 3
2013 8
2014 12
2015 7
2016 7
2017 8
2018 8
2019 6
2020 13
2021 6
2022 5
2023 3
2024 5
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis.
Rauber S, Mohammadian H, Schmidkonz C, Atzinger A, Soare A, Treutlein C, Kemble S, Mahony CB, Geisthoff M, Angeli MR, Raimondo MG, Xu C, Yang KT, Lu L, Labinsky H, Saad MSA, Gwellem CA, Chang J, Huang K, Kampylafka E, Knitza J, Bilyy R, Distler JHW, Hanlon MM, Fearon U, Veale DJ, Roemer FW, Bäuerle T, Maric HM, Maschauer S, Ekici AB, Buckley CD, Croft AP, Kuwert T, Prante O, Cañete JD, Schett G, Ramming A. Rauber S, et al. Among authors: prante o. Nat Immunol. 2024 Apr;25(4):682-692. doi: 10.1038/s41590-024-01774-4. Epub 2024 Feb 23. Nat Immunol. 2024. PMID: 38396288
N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy.
Krug J, Rodrian G, Petter K, Yang H, Khoziainova S, Guo W, Bénard A, Merkel S, Gellert S, Maschauer S, Spermann M, Waldner M, Bailey P, Pilarsky C, Liebl A, Tripal P, Christoph J, Naschberger E, Croner R, Schellerer VS, Becker C, Hartmann A, Tüting T, Prante O, Grützmann R, Grivennikov SI, Stürzl M, Britzen-Laurent N. Krug J, et al. Among authors: prante o. Gastroenterology. 2023 Mar;164(3):392-406.e5. doi: 10.1053/j.gastro.2022.11.018. Epub 2022 Nov 17. Gastroenterology. 2023. PMID: 36402190 Free PMC article.
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management.
Giesel FL, Koerber SA, Hadaschik B, Kiefer S, Schwarzenboeck S, Rahbar K, Derlin T, Grott CA, Heck M, Jilg C, Meyer PT, Ruf J, Schmidt K, Kotzerke J, la Fougère C, Reischl G, Virgolini I, Herrmann K, Burger IA, Lorenzini T, Werner M, Stenzinger A, Schwamborn K, Radtke JP, Hohenfellner M, Debus J, Weber WA, Haberkorn U, Kopka K, Eiber M; 68Ga-PSMA-11 DKTK trial contributors. Giesel FL, et al. Eur J Nucl Med Mol Imaging. 2025 Nov 15. doi: 10.1007/s00259-025-07540-4. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 41240091
Structure-guided discovery of orexin receptor-binding PET ligands.
Distler K, Maschauer S, Neu E, Hübner H, Einsiedel J, Prante O, Gmeiner P. Distler K, et al. Among authors: prante o. Bioorg Med Chem. 2024 Aug 1;110:117823. doi: 10.1016/j.bmc.2024.117823. Epub 2024 Jun 28. Bioorg Med Chem. 2024. PMID: 38964170 Free article.
Bioconjugation of a Fibroblast Activation Protein Targeted Interleukin-4.
Ruopp M, Zhu S, Worschech R, Haas D, Maschauer S, Prante O, Meinel L, Lühmann T. Ruopp M, et al. Among authors: prante o. ACS Biomater Sci Eng. 2023 Oct 9;9(10):5580-5588. doi: 10.1021/acsbiomaterials.3c00879. Epub 2023 Sep 18. ACS Biomater Sci Eng. 2023. PMID: 37721169
Radioligands for the dopamine receptor subtypes.
Prante O, Maschauer S, Banerjee A. Prante O, et al. J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):130-48. doi: 10.1002/jlcr.3000. J Labelled Comp Radiopharm. 2013. PMID: 24285319 Review.
108 results